Understanding X-linked Myotubular Myopathy and Gene Therapy

What is the primary cause of muscle weakness in X-linked Myotubular Myopathy?

• A deficiency in vitamin D

• Excessive exercise

• A mutation in the MTM1 gene

• A viral infection

Which group is most commonly affected by XL MTM?

• Both males and females equally

• Elderly individuals

• Males, primarily from birth or early childhood

• Females of all ages

What is the main goal of the investigational gene therapy for XL MTM?

• To eliminate the need for any medical intervention

• To increase the production of Myotubularin and improve muscle function

• To completely cure the disease

• To provide a temporary relief from symptoms

How is the functional MTM1 gene delivered to the cells in the gene therapy?

• Via direct muscle injection

• By dietary supplements

• Using an adeno-associated virus (AAV) vector

• Through oral medication

What is the expected outcome of the gene therapy for XL MTM?

• Permanent immunity to all genetic diseases

• Improved muscle strength and breathing functions

• No change in the patient's condition

• Complete reversal of all disease effects